BSE: 532865 | NSE: MEGH | Pesticides & Agrochemicals | Small Cap
Past 10 year’s financial track record analysis by Moneyworks4me indicates that Meghmani Organics Ltd. - (Amalgamated) is a below average quality company.
The key valuation ratios of Meghmani Organics Ltd. - (Amalgamated)'s currently when compared to its past seem to suggest it is in the Undervalued zone.
No data found
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
| Mar'11 | Mar'12 | Mar'13 | Mar'14 | Mar'15 | Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % ⓘ | 6.7% | 3.8% | 2.5% | 2.4% | 6.7% | 6.4% | 6.9% | 8.5% | 14.1% | 15.2% | - |
| Value Creation Index ⓘ | -0.5 | -0.7 | -0.8 | -0.8 | -0.5 | -0.5 | -0.5 | -0.4 | 0.0 | 0.1 | - |
Growth Parameters ⓘGrowth Parameters Colour Code Guide ⓘ | |||||||||||
| Sales ⓘ | 865 | 822 | 750 | 893 | 948 | 959 | 1,046 | 1,238 | 1,410 | 1,625 | 1,623 |
| Sales YoY Gr. | - | -5% | -8.8% | 19.2% | 6.2% | 1.2% | 9.1% | 18.3% | 13.9% | 15.2% | - |
| Adj EPS ⓘ | 1.6 | 0.5 | 0.1 | -0.1 | 1.2 | 1.3 | 1.6 | 2.6 | 5.1 | 6.4 | 7.3 |
| YoY Gr. | - | -68.7% | -76.5% | -158.3% | NA | 8.3% | 23.7% | 61.7% | 93.9% | 25.4% | - |
| BVPS (₹) ⓘ | 21 | 20.7 | 21 | 21.2 | 22.3 | 23.3 | 24.9 | 27.4 | 33 | 39 | 46.9 |
| Adj Net Profit ⓘ | 41.6 | 13 | 3 | -1.8 | 30.8 | 33.3 | 41.3 | 66.8 | 129 | 162 | 185 |
| Cash Flow from Ops. ⓘ | 76.6 | 80.6 | 68.3 | 47.6 | 142 | 79.3 | 115 | 178 | 115 | 234 | - |
| Debt/CF from Ops. ⓘ | 4.2 | 4.1 | 5.5 | 9.1 | 2.7 | 4.9 | 2.9 | 2.4 | 2.8 | 1.1 | - |
CAGR Colour Code Guide ⓘ
| 9 Years | 5 Years | 3 Years | 1 Years | |||||
|---|---|---|---|---|---|---|---|---|
| Sales ⓘ | 7.3% | 11.4% | 15.8% | 15.2% | ||||
| Adj EPS ⓘ | 16.4% | 39.4% | 57.8% | 25.4% | ||||
| BVPSⓘ | 7.1% | 11.9% | 16.1% | 18.2% | ||||
| Share Price | 21.7% | -0.5% | -17.8% | -53.6% | ||||
Performance Ratio Colour Code Guide ⓘ
| Mar'11 | Mar'12 | Mar'13 | Mar'14 | Mar'15 | Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity % ⓘ | 8.1 | 2.5 | 0.6 | -0.3 | 5.6 | 5.8 | 6.7 | 10 | 16.8 | 17.7 | 17 |
| Op. Profit Mgn % ⓘ | 10 | 9.1 | 7.6 | 6.5 | 10.7 | 12.5 | 12.7 | 14.1 | 16.7 | 14.6 | 17.3 |
| Net Profit Mgn % ⓘ | 4.8 | 1.6 | 0.4 | -0.2 | 3.3 | 3.5 | 3.9 | 5.4 | 9.2 | 10 | 11.4 |
| Debt to Equity ⓘ | 0.6 | 0.6 | 0.7 | 0.8 | 0.7 | 0.7 | 0.5 | 0.6 | 0.4 | 0.3 | 0.1 |
| Working Cap Days ⓘ | 239 | 256 | 283 | 258 | 234 | 223 | 215 | 191 | 192 | 189 | 96 |
| Cash Conv. Cycle ⓘ | 126 | 137 | 150 | 131 | 121 | 123 | 106 | 94 | 104 | 100 | 41 |
No data to display
Return on Equity has declined versus last 3 years average to %
Sales growth has been subdued in last 3 years %
Net Profit has been subdued in last 3 years %
Sales growth is not so good in last 4 quarters at %
| Standalone | Consolidated | |
|---|---|---|
| TTM EPS (₹) | 7.3 | 7.3 |
| TTM Sales (₹ Cr.) | 1,623 | 1,637 |
| BVPS (₹.) ⓘ | 46.9 | 47.1 |
| Reserves (₹ Cr.) ⓘ | 1,167 | 1,173 |
| P/BV ⓘ | 2.94 | 2.93 |
| PE ⓘ | 18.97 | 18.82 |
| From the Market | |
|---|---|
| 52 Week Low / High (₹) | 64.05 / 141.35 |
| All Time Low / High (₹) | 3.76 / 153.70 |
| Market Cap (₹ Cr.) | 3,510 |
| Equity (₹ Cr.) | 25.4 |
| Face Value (₹) | 1 |
| Industry PE ⓘ | 35.3 |
| Pledged * | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PARTICULARS | Mar'11 | Mar'12 | Mar'13 | Mar'14 | Mar'15 | Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 864.92 | 822.10 | 749.74 | 893.28 | 948.18 | 959.11 | 1,046.19 | 1,238 | 1,410.42 | 1,624.65 |
| Operating Expenses ⓘ | 778.52 | 747.50 | 696.81 | 846.23 | 861.33 | 847.85 | 912.99 | 1,066.81 | 1,178.15 | 1,388.37 |
| Manufacturing Costs | 118.76 | 126.09 | 132.41 | 161.96 | 167.69 | 188.63 | 179.14 | 228.16 | 221.38 | 224.05 |
| Material Costs | 572.83 | 541.11 | 486.29 | 565.77 | 581.34 | 549.89 | 641.47 | 706.75 | 810.77 | 1,006.68 |
| Employee Cost | 32.84 | 28.66 | 31.13 | 39.40 | 51.05 | 39.85 | 44.08 | 48.23 | 53.79 | 64.71 |
| Other Costs ⓘ | 54.10 | 51.64 | 46.98 | 79.10 | 61.24 | 69.49 | 48.29 | 83.67 | 92.21 | 92.93 |
| Operating Profit ⓘ | 86.40 | 74.60 | 52.93 | 47.05 | 86.86 | 111.27 | 133.20 | 171.19 | 232.27 | 236.28 |
| Operating Profit Margin (%) | 10.0% | 9.1% | 7.1% | 5.3% | 9.2% | 11.6% | 12.7% | 13.8% | 16.5% | 14.5% |
| Other Income ⓘ | 11.53 | 9.75 | 10.34 | 34.37 | 31.58 | 24.01 | 10.96 | 26.11 | 38.82 | 78.12 |
| Interest ⓘ | 17.32 | 27.80 | 27.24 | 35.01 | 47.66 | 41.31 | 36.42 | 30.87 | 45.89 | 31.42 |
| Depreciation ⓘ | 20.35 | 26.08 | 26.36 | 31.34 | 35.03 | 36.19 | 38.47 | 42.62 | 46.29 | 47.52 |
| Exceptional Items ⓘ | -0.25 | 0 | -0.87 | -0.50 | -3.51 | -8.11 | -3.81 | -2.36 | 43.29 | 0 |
| Profit Before Tax ⓘ | 60 | 30.47 | 8.80 | 14.56 | 32.24 | 49.67 | 65.47 | 121.45 | 222.19 | 235.45 |
| Tax ⓘ | 12.82 | 13.89 | 3.02 | 2.99 | 6.03 | 13.39 | 23.96 | 44.52 | 53.50 | 42.54 |
| Profit After Tax | 47.18 | 16.58 | 5.78 | 11.58 | 26.22 | 36.28 | 41.51 | 76.93 | 168.69 | 192.92 |
| PAT Margin (%) | 5.5% | 2.0% | 0.8% | 1.3% | 2.8% | 3.8% | 4.0% | 6.2% | 12.0% | 11.9% |
| Adjusted EPS (₹) | 1.9 | 0.7 | 0.2 | 0.5 | 1.0 | 1.4 | 1.6 | 3.0 | 6.6 | 7.6 |
| Dividend Payout Ratio (%) | 22% | 15% | 44% | 22% | 39% | 21% | 25% | 13% | 15% | 13% |
| PARTICULARS | Mar'11 | Mar'12 | Mar'13 | Mar'14 | Mar'15 | Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 |
|---|---|---|---|---|---|---|---|---|---|---|
Equity and Liabilities | ||||||||||
| Shareholders Fund | 533.25 | 527.10 | 534.38 | 539.57 | 565.96 | 591.60 | 632.91 | 697.70 | 837.97 | 990.81 |
| Share Capital ⓘ | 25.43 | 25.43 | 25.43 | 25.43 | 25.43 | 25.43 | 25.43 | 25.43 | 25.43 | 25.43 |
| Reserves ⓘ | 507.82 | 501.67 | 508.95 | 514.14 | 540.53 | 566.16 | 607.48 | 672.27 | 812.53 | 965.37 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debt | 312.63 | 312.24 | 359.25 | 370.98 | 330.78 | 362.01 | 311.58 | 375.33 | 284.85 | 222.84 |
| Long Term Debt | 138 | 129.37 | 112.81 | 125 | 133.50 | 103.34 | 76.98 | 217.41 | 85.27 | 55.58 |
| Short Term Debt | 174.63 | 182.87 | 246.43 | 245.98 | 197.28 | 258.67 | 234.60 | 157.92 | 199.57 | 167.26 |
| Trade Payables | 109.44 | 97.34 | 134.18 | 163.16 | 127.66 | 162.92 | 154.73 | 170.19 | 222.90 | 234.67 |
| Others Liabilities ⓘ | 78.87 | 96.36 | 102.14 | 166.42 | 130.24 | 80.54 | 92.67 | 135.11 | 157.87 | 195.35 |
| Total Liabilities ⓘ | 1,034.19 | 1,033.05 | 1,129.95 | 1,240.13 | 1,154.65 | 1,197.07 | 1,191.90 | 1,378.33 | 1,503.58 | 1,643.67 |
Fixed Assets | ||||||||||
| Gross Block | 339.15 | 420.72 | 455.39 | 598.60 | 650.29 | 419.20 | 458.79 | 565.55 | 595.44 | 681.18 |
| Accumulated Depreciation | 147.81 | 173.09 | 198.74 | 227.78 | 262.40 | 36.19 | 74.66 | 117.28 | 156.13 | 200.67 |
| Net Fixed Assetsⓘ | 191.34 | 247.63 | 256.65 | 370.82 | 387.89 | 383.02 | 384.14 | 448.27 | 439.31 | 480.51 |
| CWIP ⓘ | 46.28 | 53.28 | 88.84 | 21.34 | 15.59 | 22.51 | 16.01 | 24.61 | 49.34 | 100.76 |
| Investmentsⓘ | 147.67 | 113.93 | 138.08 | 138.08 | 138.59 | 124.84 | 125.02 | 233.72 | 183.04 | 183.09 |
| Inventories | 129.26 | 136.24 | 148.23 | 208.60 | 180.82 | 263.87 | 209.04 | 232.65 | 363.61 | 296.54 |
| Trade Receivables | 325.58 | 321.80 | 328.23 | 331.17 | 302.60 | 294.86 | 297.77 | 302.84 | 354.12 | 463.79 |
| Cash Equivalents | 9.91 | 9.81 | 1.75 | 7.65 | 11.21 | 9.68 | 9.19 | 1.88 | 3.13 | 8.28 |
| Others Assetsⓘ | 184.16 | 150.35 | 168.17 | 162.46 | 117.94 | 98.28 | 150.74 | 134.35 | 111.02 | 110.69 |
| Total Assets ⓘ | 1,034.19 | 1,033.05 | 1,129.95 | 1,240.13 | 1,154.65 | 1,197.07 | 1,191.90 | 1,378.33 | 1,503.58 | 1,643.67 |
| PARTICULARS | Mar'11 | Mar'12 | Mar'13 | Mar'14 | Mar'15 | Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow From Operating Activity ⓘ | 76.64 | 80.57 | 68.25 | 47.63 | 141.75 | 79.31 | 115.43 | 177.75 | 114.94 | 233.52 |
| PBT ⓘ | 60 | 30.47 | 8.80 | 14.56 | 32.24 | 49.67 | 65.47 | 121.45 | 222.19 | 235.45 |
| Adjustment ⓘ | 51.95 | 60.58 | 49.26 | 72.59 | 62.58 | 85.31 | 82.87 | 75.81 | 51.90 | 28.86 |
| Changes in Working Capital ⓘ | -19.63 | -4.24 | 10.64 | -30.38 | 52.9 | -38.85 | -19.3 | -0.33 | -110.23 | 15 |
| Tax Paid ⓘ | -15.68 | -6.23 | -0.45 | -9.16 | -5.98 | -16.83 | -13.60 | -19.17 | -48.92 | -45.79 |
| Cash Flow From Investing Activity ⓘ | -105.96 | -34.49 | -58.83 | -80.21 | -32.11 | -33.08 | -28.21 | -217.56 | -58.64 | -93.19 |
| Capex | -74.69 | -88.88 | -59.78 | -52.27 | -52.65 | -35.88 | -30.76 | -118.77 | -73.55 | -121.32 |
| Net Investments | -16.82 | 35.67 | -0.02 | -0.02 | -0.03 | -0.03 | 0 | 6.96 | -0.50 | -2.92 |
| Others ⓘ | -14.45 | 18.72 | 0.96 | -27.91 | 20.57 | 2.83 | 2.56 | -105.74 | 15.41 | 31.04 |
| Cash Flow From Financing Activityⓘ | 40.57 | -45.50 | -16.07 | 40.63 | -104.40 | -49.11 | -87.55 | 39.97 | -55.76 | -134.46 |
| Net Proceeds from Shares ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Proceeds from Borrowing ⓘ | -22.18 | -61.91 | -1.84 | 67.49 | -17.97 | 75.02 | -26.50 | 160.50 | -136.83 | -34.17 |
| Interest Paid ⓘ | -18.63 | -28.79 | -31.85 | -46.87 | -46.74 | -41.56 | -36.93 | -31.59 | -43.92 | -21.71 |
| Dividend Paid ⓘ | -10.12 | -10.12 | -2.53 | -2.53 | -12.55 | -7.63 | 0 | -10.18 | -24.42 | -36.37 |
| Others ⓘ | 91.51 | 55.33 | 20.14 | 22.54 | -27.13 | -74.94 | -24.12 | -78.75 | 149.42 | -42.21 |
| Net Cash Flow ⓘ | 11.26 | 0.58 | -6.66 | 8.05 | 5.24 | -2.88 | -0.32 | 0.17 | 0.55 | 5.87 |
| PARTICULARS | Mar'11 | Mar'12 | Mar'13 | Mar'14 | Mar'15 | Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ratios | ||||||||||
| ROE (%) | 9.15 | 3.13 | 1.09 | 2.16 | 4.74 | 6.27 | 6.78 | 11.56 | 21.97 | 21.1 |
| ROCE (%) | 9.65 | 6.81 | 4.08 | 5.26 | 8.29 | 9.41 | 10.45 | 14.58 | 23.48 | 22.06 |
| Asset Turnover Ratio | 0.95 | 0.86 | 0.75 | 0.8 | 0.85 | 0.88 | 0.94 | 0.99 | 0.99 | 1.04 |
| PAT to CFO Conversion(x) | 1.62 | 4.86 | 11.81 | 4.11 | 5.41 | 2.19 | 2.78 | 2.31 | 0.68 | 1.21 | Working Capital Days |
| Receivable Days | 128 | 133 | 147 | 127 | 114 | 106 | 97 | 86 | 84 | 91 |
| Inventory Days | 49 | 54 | 64 | 68 | 70 | 79 | 77 | 63 | 76 | 74 |
| Payable Days | 66 | 70 | 87 | 96 | 91 | 96 | 90 | 84 | 88 | 83 |
It was in 1986, when Gujarat Industries was established as a partnership firm in Gujarat to manufacture pigments. High productivity and profitability transformed Gujarat Industries to a joint stock company, under the name of Meghmani Organics Limited, by 1995. Since then Meghmani Organics Limited has diversified its business interests to include a range of pesticides and other pigment products as well.
Meghmani Organics Limited is a leading manufacturer of pigment and pesticide products in the country and is the recipient of several prestigious awards in recognition of its outstanding business performance.
Sound fundamentals, outstanding export performance, strong presence in the domestic market and a focused management team has seen Meghmani Organics Limited grow at a compounded annual growth rate (CAGR) of 17% and profits 10% over the past 3 years.
The Rs 6000 million Meghmani Organics Limited is:
More than 80% of its pigment products and over 50% of its pesticides products are exported the world over. The company has four multifunctional production facilities in Gujarat (India) of which three are ISO 9001-2000. The production facilities are strategically located with high accessibility and close proximity to source of raw material.
The company has the necessary facilities to treat liquid / solid waste and air emission that contain pollutants, in accordance with the requirements of the Gujarat Pollution Control Board ('GPCB'). It is ISO certified and follow sound Health, Safety and Environmental policy.
The production facility of company is situated in Gujarat. It had two pigment production plants in Vatva and Panoli near Ahmedabad and two agrochemical plants in Chharodi and Ankleshwar.
Product range of the company includes:
Pigments- The pigment products which are manufactured basically fall into three main categories -- Pigments for Plastics - Pigments for Printing Inks - Pigments for Coatings
Pesticides- The agrochemical products which are manufactured fall into three main categories -- Technical Products - Formulation Products - IntermediatesIts agrochemical products are used in crop protection, public health, termite & insect control and veterinary applications.
New Products- Hysol-P based CPC Blue product.
Milestones of the company:
Awards/Achievements
MoneyWorks4Me rating and ranking of funds for SIP is available to subscribers only. Moneyworks4Me is not a rating and ranking agency, however it is required that users have a way of selecting funds and building a Portfolio. The method used by it are described below to enable users to understand the logic behind the rating and ranking Subscriber will find more details on this in the various content made available from time to time. In case you need more please write to besafe@moneyworks4Me.com
MoneyWorks4Me rates and ranks mutual funds based on the following data-driven system:
Funds ranking in screeners: Performance Consistency and Quality are two parameters used for ranking funds for SIP. The ranking as follows GG, GO, GR, OG, OO, OR, RG, RO and RR.
With the same color-coded funds, the one with the higher Average 3-year rolling returns (over 5 to 10 years), the number that appears in the Performance tag, ranks higher.
Here is the summary:
The third tag Upside Potential is not relevant for SIP. It is relevant for lumpsum investments in Mutual Funds.
Buy quality Stocks when they are available at reasonable prices and supported by an upward price trend and Sell when they are Overvalued using the Decizen Rating System. Covers 3500+ stocks
Download APP
